Suggestions
Art Howe
Biotechnology and Technology Founder serving as CEO and/or CFO
Art Howe is a former Pulitzer Prize-winning journalist with a diverse background in media, technology, and life science companies.
Having co-founded Imvax™ in 2015, Howe focuses on developing patient-specific immunotherapies for treating cancers like malignant gliomas.
Prior to Imvax, Howe was involved in the media and technology industry, founding over 30 newspapers, specialty publications, and tech startups.
Co-founding Verve in 2005, Howe was a key player in the transformation of media consumption through mobile technology.
Throughout his career, Howe has been a board member and advisor for various technology and media companies, including Candid, a leading information source on non-profits.
A recipient of prestigious awards like the Pulitzer Prize, Howe holds a BA in Philosophy from the University of Pennsylvania and an MBA from The Wharton School.